Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Jaehde

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Biopharmaceutics & Drug Disposition|September 23, 2009
Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype ratsSilke Retlich, Barbara Withopf, Andreas Greischel, et al.
Cancer Medicine|August 9, 2022
Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracilEduard Schmulenson, Nigina Zimmermann, Lothar Müller, et al.
BMC Geriatrics|February 13, 2019
Pharmacist-led medication reviews for geriatric residents in German long-term care facilitiesKerstin Bitter, Christina Pehe, Manfred Krüger, et al.
Pharmacy World & Science : PWS|July 8, 2005
Psychometric assessment and application of a questionnaire measuring patient: satisfaction with information on cancer treatmentAndrea Liekweg, Meike Eckhardt, Suzanne C Malfair Taylor, et al.
Scientia Pharmaceutica|March 8, 2017
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical ApplicationTomi Hendrayana, André Wilmer, Verena Kurth, et al.
Cancer Chemotherapy and Pharmacology|August 28, 2020
Evaluation of patient-reported severity of hand-foot syndrome under capecitabine using a Markov modeling approachEduard Schmulenson, Linda Krolop, Sven Simons, et al.
BMC Cancer|June 21, 2008
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cellsGanna V Kalayda, Christina H Wagner, Irina Buss, et al.
Anti-Cancer Drugs|March 17, 2009
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicityPaola Milla, Mario Airoldi, Günther Weber, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 3, 2015
GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cellsMaximilian Kullmann, Sandra Kotz, Malte Hellwig, et al.
Electrophoresis|August 8, 2015
Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adductsSandra Kotz, Maximilian Kullmann, Barbara Crone, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Biopharmaceutics & Drug Disposition|September 23, 2009
Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype ratsSilke Retlich, Barbara Withopf, Andreas Greischel, et al.
Cancer Medicine|August 9, 2022
Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracilEduard Schmulenson, Nigina Zimmermann, Lothar Müller, et al.
BMC Geriatrics|February 13, 2019
Pharmacist-led medication reviews for geriatric residents in German long-term care facilitiesKerstin Bitter, Christina Pehe, Manfred Krüger, et al.
Pharmacy World & Science : PWS|July 8, 2005
Psychometric assessment and application of a questionnaire measuring patient: satisfaction with information on cancer treatmentAndrea Liekweg, Meike Eckhardt, Suzanne C Malfair Taylor, et al.
Scientia Pharmaceutica|March 8, 2017
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical ApplicationTomi Hendrayana, André Wilmer, Verena Kurth, et al.
Cancer Chemotherapy and Pharmacology|August 28, 2020
Evaluation of patient-reported severity of hand-foot syndrome under capecitabine using a Markov modeling approachEduard Schmulenson, Linda Krolop, Sven Simons, et al.
BMC Cancer|June 21, 2008
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cellsGanna V Kalayda, Christina H Wagner, Irina Buss, et al.
Anti-Cancer Drugs|March 17, 2009
Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicityPaola Milla, Mario Airoldi, Günther Weber, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 3, 2015
GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cellsMaximilian Kullmann, Sandra Kotz, Malte Hellwig, et al.
Electrophoresis|August 8, 2015
Combination of two-dimensional gel electrophoresis and a fluorescent carboxyfluorescein-diacetate-labeled cisplatin analogue allows the identification of intracellular cisplatin-protein adductsSandra Kotz, Maximilian Kullmann, Barbara Crone, et al.
Pageof 16